EDGAR Filing Documents for 0000000000-20-008431

Form UPLOAD - SEC-generated letter:

SEC Accession No. 0000000000-20-008431

Filing Date

2020-09-08

Accepted

2020-09-08 15:09:18

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.pdf	LETTER	27660
2		filename2.txt	TEXT-EXTRACT	1494
	Complete submission text file	0000000000-20-008431.txt		40343

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406

Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640

Nabriva Therapeutics plc (Filed for) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations